Creating diversity and novelty in drug discovery

Zerenex Molecular™ has launched a new collection of over 4000 diverse and unique compounds within the Novel Chemical Entities - NCE™ collection.

These rare heterocyclic (small (hetero) cyclic (fused) ring compounds containing one or more chemical handles) including imidazoles, pyridines, pyrazines etc as well as a variety of alycyclic (piperizines, piperidines) and aromatic compounds will continue to assist medicinal and synthetic chemists globally in developing hit generation and hit-to-lead optimization libraries.

Using innovative chemistry, the company has designed, synthesized and acquired a variety of unique building blocks, key to creating diversity and novelty in drug discovery programmes.

Since its inception Zerenex Molecular™ continues to develop and strengthen its global reputation for specializing in the synthesis and supply of unusual small molecule compounds to the pharmaceutical and biotech industries.